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http://www.biomedcentral.com/1471-2393/13/143RESEARCH ARTICLE Open AccessElevated maternal lipids in early pregnancy are
not associated with risk of intrapartum caesarean
in overweight and obese nulliparous women
Elaine M Fyfe1,4*, Karen S Rivers2, John MD Thompson3, Kamala PL Thiyagarajan2, Katie M Groom1,
Gustaaf A Dekker2, Lesley ME McCowan1 and On behalf of the SCOPE consortiumAbstract
Background: Maternal overweight and obesity are associated with slower labour progress and increased caesarean
delivery for failure to progress. Obesity is also associated with hyperlipidaemia and cholesterol inhibits myometrial
contractility in vitro. Our aim was, among overweight and obese nulliparous women, to investigate 1. the role of
early pregnancy serum cholesterol and 2. clinical risk factors associated with first stage caesarean for failure to
progress at term.
Methods: Secondary data analysis from a prospective cohort of overweight/obese New Zealand and Australian
nullipara recruited to the SCOPE study. Women who laboured at term and delivered vaginally (n=840) or required
first stage caesarean for failure to progress (n=196) were included. Maternal characteristics and serum cholesterol at
14–16 weeks’ of gestation were compared according to delivery mode in univariable and multivariable analyses
(adjusted for BMI, maternal age and height, obstetric care type, induction of labour and gestation at delivery ≥41 weeks).
Results: Total cholesterol at 14–16 weeks was not higher among women requiring first stage caesarean for failure to
progress compared to those with vaginal delivery (5.55 ± 0.92 versus 5.67 ± 0.85 mmol/L, p= 0.10 respectively). Antenatal
risk factors for first stage caesarean for failure to progress in overweight and obese women were BMI (adjusted odds
ratio [aOR (95% CI)] 1.15 (1.07-1.22) per 5 unit increase, maternal age 1.37 (1.17-1.61) per 5 year increase, height 1.09
(1.06-1.12) per 1cm reduction), induction of labour 1.94 (1.38-2.73) and prolonged pregnancy ≥41 weeks 1.64 (1.14-2.35).
Conclusions: Elevated maternal cholesterol in early pregnancy is not a risk factor for first stage caesarean for failure to
progress in overweight/obese women. Other clinically relevant risk factors identified are: increasing maternal BMI,
increasing maternal age, induction of labour and prolonged pregnancy ≥41 weeks’ of gestation.
Keywords: Cholesterol, Antenatal, Delivery, Obesity, LabourBackground
Caesarean delivery in overweight and obese women is
associated with increased morbidity and mortality, along
with increased utilisation of health care resources [1].
Increasing maternal body mass index (BMI) is associated
with a dose dependent elevated risk of emergency
caesarean section in labour, which is largely due to failure
to progress [1-5]. We have previously demonstrated that* Correspondence: e.fyfe@auckland.ac.nz
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reproduction in any medium, provided the orthis elevated risk is confined to the first stage of labour,
and rates of caesarean in the second stage of labour do
not differ according to BMI [4].
Factors that differentiate overweight and obese women
who deliver vaginally from those who require intrapartum
caesarean have not previously been reported. The ability to
identify those overweight and obese women in early
pregnancy who are at higher risk for caesarean in labour at
term might assist with delivery planning and counselling.
The underlying reason for failure to progress is thought
to be reduced uterine contractility [5]. Reduced contractility
in term myometrial biopsies has been reported in specimens
from overweight and obese women compared with those. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Vaginal birth n=840 1st stage caesarean for failure to 
progress n=196 
1st stage caesarean NOT for failure to progress 
n=83
2nd stage caesarean n=64 
Final study population n=1036
BMI <25.0 n=1742
Preterm births n= 105
Prelabour caesarean n= 138
Missing lipids n=2 
Recruited to study (N=3234)
Pregnancy ended <20wks n=14
Termination/miscarriage >20wks n=12
Ineligible status identified after recruitment n=12 
Lost to follow up n=26 
Initial study population n=3170
laboured at term n=1183 
Figure 1 Recruitment flow chart.
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cervical dilation in labour is slower in overweight and obese
women [6]. However, the mechanisms underlying the
association between elevated BMI and caesarean
section for failure to progress in overweight and obese
women are not understood. The relative hyperlipidaemia of
normal pregnancy is exaggerated in obese women [7] and it
has been speculated that obesity related dyslipidaemia
may contribute to altered myometrial cell signalling,
dysfunctional labour and increased caesarean delivery
for failure to progress [8].
Among overweight and obese women, the level of
serum cholesterol may differentiate those who display
impaired myometrial function and require caesarean
section in labour from those who progress to a vaginal
birth. This association has not previously been investigated.
We aimed to investigate the relationship between
maternal characteristics, including serum cholesterol,
and the risk of caesarean for failure to progress in the
first stage of labour among overweight and obese
women. We hypothesised that overweight and obese
nulliparous women at term who required a caesarean in
the first stage of labour for failure to progress would have
higher serum cholesterol levels at 14–16 weeks’ of gestation
compared with those who had a vaginal delivery.
Methods
Participants were healthy, nulliparous women recruited
to the Screening for Pregnancy Endpoints Study
(SCOPE) from Auckland, New Zealand and Adelaide,
Australia [9]. This is a secondary analysis of data from
the SCOPE study, a multicentre prospective cohort
study with the primary aim of developing screening tests
for prediction of preeclampsia, spontaneous preterm
birth and small for gestational age babies. Ethical
approval was obtained from local ethics committees (New
Zealand AKX/02/00/364, Australia REC 1712/5/2008) and
all women provided written informed consent. The popula-
tion for the current study comprised overweight and obese
women who laboured at term (Figure 1) and either deliv-
ered vaginally (spontaneous or operative) or had a caesarean
in the first stage of labour for failure to progress. Women
who had a caesarean in the first stage of labour for any
reason other than failure to progress or had a caesarean in
the second stage of labour were excluded.
Detailed data collected from all participants during inter-
view with a research midwife, at 14–16 weeks gestation,
have previously been described in detail [10] and included
demographic information, smoking, family, medical and
gynaecological history. Maternal measurements recorded at
14–16 weeks of gestation included blood pressure, height
and weight. Maternal BMI was calculated at 14-16weeks’ of
gestation using maternal weight divided by height
squared (kg/m2) measured to the nearest kilogramand centimetre respectively. Overweight and obesity
were defined according to conventional WHO criteria
as BMI 25–29.99 and ≥ 30 kg/m2 respectively [11].
Non-fasting serum cholesterol was measured from
bloods drawn at the time of interview at 14–16
weeks’ of gestation in the SCOPE study. Blood
specimen collection and preparation of serum were
performed using standard operating procedures, and
samples were stored at −80°C within four hours of
collection. Measurements were performed in two
batches in 2008. Samples were measured using the
cobas® Cholesterol CHOD-PAP kit (Roche/Hitachi).
Co-efficient of variation was 0.8% and 1.7% for within
and between-run respectively.Outcome measures and exposures
The primary outcome measure was mode of delivery
classified as vaginal [spontaneous or operative (forceps
or ventouse)] or caesarean in first stage of labour for
failure to progress. The exposure was non-fasting serum
cholesterol level measured at 14–16 weeks of gestation.
Cholesterol measurements (mmol/L) included total
cholesterol, high density lipoprotein (HDL)-cholesterol,
low density lipoprotein (LDL)-cholesterol, and total
cholesterol: HDL-cholesterol ratio.
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Estimated date of delivery was calculated from a certain
last menstrual period date and only adjusted if either an
ultrasound scan at less than 16 weeks’ gestation found a
difference of seven or more days between the scan gesta-
tion and that calculated by the last menstrual period, or
at a 20 week scan a difference of 10 or more days was
found between the scan gestation and that calculated
from the last menstrual period. If the last menstrual
period date was uncertain, scan dates were used to
calculate the estimated date of delivery [9]. Socioeconomic
index was a measure of socioeconomic status derived
from maternal occupation [12]. Private obstetric care was
that provided by a private obstetrician and the comparison
group included care that was hospital based, or provided
by an independent midwife or a general practitioner.
Definitions for gestational hypertension and preeclampsia
have previously been described in detail [10,13]. Term
delivery was delivery at 37° or greater weeks of gestation.
Active labour was defined as regular, painful uterine
contractions with progressive cervical effacement and
dilation and cervical dilatation ≥3 cms [14]. Emergency
caesarean in labour was delivery required because of an
emergency situation in active labour (e.g. failure to
progress, fetal distress) when the caesarean was performed
having not been previously considered necessary [15].
Indication for caesarean stated on the delivery summary by
the attending doctor was used to determine whether
caesarean in first stage was performed for failure to
progress or another indication. Participating hospitals had
standard protocols for management of dysfunctional
labour in nulliparous women which included rupture
of membranes and oxytocin augmentation which preceded
diagnosis of failure to progress. If there were combined
indications which included failure to progress, then the
indication was recorded as failure to progress. Gestational
Diabetes Mellitus was defined in accordance with The
Australian Diabetes in Pregnancy Society [16]. Small for
gestational age (SGA) and large for gestational age (LGA)
were infants with birthweight <10th customised centile
and >90th customised centile respectively, adjusted for
infant sex, gestation at delivery and maternal characteristics:
parity, ethnicity, height and booking weight [17].
Statistical analysis
Data were entered into an internet accessed, auditable data-
base (Medscinet AB, Sweden). Data analysis was performed
using the statistical software package SAS version 9.2.
Univariable analysis was performed to compare maternal
characteristics and birth outcomes between women who
had a vaginal delivery (spontaneous or operative) and
women who had a first stage caesarean for failure to
progress. Vaginal birth was the referent group. The chi
square test was used for analysis of categorical variables,and a Student’s t-test was used to compare continuous
variables. For continuous variables we investigated the
shape of the relationship using Generalised Additive
Models (GAMs) [18]. There were no missing data for any
variables used in this analysis. Adjusted odds ratios were
calculated using multivariable logistic regression, control-
ling for all variables significant at p<0.1 in univariable
analyses, and all maternal cholesterol measures as a priori
variables. With our sample size (N=1036, 840 vaginal
and 196 caesarean births) we are able to detect a
difference of 0.2 mmol/L in total cholesterol between
the groups (alpha of 0.05 and power 80%). Therefore,
we are able to detect any differences that would be
considered clinically significant and which are greater
than 0.2 mmols.
Results
Between November 2004 and Oct 2008, 3234 women
were recruited to the SCOPE study in Auckland and
Adelaide and follow up was complete in 3195 (99%)
participants (Figure 1). The initial study population
(n=3170) included 1742 (55.0%) women with BMI<25
who were excluded from this study. Of the final eligible
study population of 1036 nulliparous overweight and
obese women who laboured at term, 840 (81.1%) had a
vaginal delivery and 196 (18.9%) had a first stage caesarean
for failure to progress. Of the women who had first stage
caesarean for failure to progress, 53 (27%) also had
fetal distress and therefore had a combined indication
for caesarean delivery.
Maternal characteristics and antenatal outcomes
Women who had a first stage caesarean for failure to
progress were older, shorter, and had a higher BMI com-
pared to those who delivered vaginally (Table 1). There
were no differences in ethnicity, socioeconomic index,
smoking, marital status or rates of gestational diabetes
or hypertensive pregnancy disorders according to mode
of delivery. Serum cholesterol levels at 14–16 weeks’ of
gestation were not higher among overweight and obese
women who had a first stage caesarean for failure to
progress compared with overweight and obese women
who delivered vaginally (Total cholesterol 5.67±0.85 v
5.55 ± 0.92, p=0.10) (Table 1). There were also no
differences in other lipid parameters (Table 1).
Labour and delivery outcomes
Of 1036 overweight and obese women at term, 677
(65%) laboured spontaneously, and 359 (35%) had labour
induced. The rate of first stage caesarean for failure
to progress following induction of labour was twice
as high as that following spontaneous onset of labour
(28% v 14%, p=<0. 001). Although women who had a
first stage caesarean for failure to progress had an
Table 1 Maternal characteristics, pregnancy and neonatal outcomes for overweight and obese nulliparous women
according to mode of delivery
Vaginal delivery 1st stage caesarean for failure to progress P
N = 840 (81%) N = 196 (19%)
Maternal characteristic
Body mass index (kg/m2)[median (IQR)] 28.0 (25.4-31.3) 29.7 (27.0-32.7) <0.001
Age (years) 27.1 ± 5.6 28.9 ± 5.9 <0.001
Ethnicity 0.18
European 732 (87) 179 (91)
Socioeconomic index 38 ± 16 39 ± 15 0.35
Smoking at 14–16 weeks 103 (12) 22 (11) 0.69
Unmarried 77 (9) 13 (7) 0.26
Maternal height (cm) 166 ± 6.4 163 ± 5.8 <0.001
Private obstetric care 83 (10) 28 (14) 0.07
Pregnancy complications
Gestational diabetes* 26 (3) 12 (6) 0.11
Gestational hypertension 85 (10) 25 (13) 0.28
Preeclampsia 46 (5) 16 (8) 0.15
Serum lipids
Total Cholesterol† 5.55 ± 0.92 5.67 ± 0.85 0.10
LDL‡- Cholesterol† 3.10 ± 0.82 3.18 ± 0.75 0.20
HDL§- Cholesterol† 1.75 ± 0.36 1.75 ± 0.34 0.87
Total Cholesterol: HDL ratio 3.29 ± 0.80 3.34 ± 0.76 0.42
Triglycerides 1.55 ± 0.63 1.62 ± 0.63 0.16
Labor and delivery
Induction of labour 259 (31) 100 (51) <0.001
Gestation at delivery (weeks) 39.6 ± 1.2 39.9 ± 1.2 0.002
Gestation at delivery ≥ 41 weeks 205 (24) 71 (36) 0.002
Neonatal outcomes
Birthweight (g) 3500 ± 445 3734 ± 484 <0.001
Customised birthweight centile 44 ± 28 57 ± 29 <0.001
Small for gestational age║ 91 (11) 12 (6) 0.05
Large for gestational age║ 56 (7) 32 (16) <0.001
Data are n (%) or mean ± standard deviation unless otherwise stated.
* Unknown n=40.
† mmol/L.
‡ low density lipoprotein.
§ high density lipoprotein.
║By customised birthweight centiles.
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only two days was not clinically significant (Table 1).
Those with caesarean for failure to progress in the
first stage of labour were more likely to have a
prolonged pregnancy (≥ 41° weeks) compared to those
who delivered vaginally. The mean customised birth-
weight centile and the rate of LGA infants was higher
among women who had a first stage caesarean for
failure to progress, and the rate of SGA infants was
lower (Table 1).Following adjustment for all variables in univariable
analysis with P value <0.1, maternal total cholesterol,
LDL, HDL and total LDL: HDL ratios were not inde-
pendently associated with risk of first stage caesarean for
failure to progress. The following variables were identi-
fied as independent antenatal risk factors for first stage
caesarean for failure to progress: decreasing maternal
height, increasing maternal age, increasing BMI, induc-
tion of labour and gestation at delivery greater than or
equal to 41 weeks (Table 2). We investigated the
Table 2 Antenatal risk factors for 1st stage caesarean for
failure to progress among overweight and obese nullipara
Antenatal factor Adjusted odds ratio
(95% confidence interval)
BMI† (per 5 units ↑) 1.40 (1.18-1.66)
Maternal age (per 5 yr ↑) 1.37 (1.17-1.61)
Maternal height (per 1 cm ↓) 1.09 (1.06-1.12)
Induction of labour 1.94 (1.38-2.73)
Gestation at delivery ≥ 41 wks 1.64 (1.14-2.35)
† kg/ m2.
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to caesarean delivery, and found that this relationship
was not significant. As birthweight is not an antenatal
risk factor, we did not include it as a variable in the final
multivariable model. However, when a secondary
analysis was undertaken that included birthweight, the
risk for caesarean doubled for every 500 g increase in
birthweight (aOR 2.19, 95% CI 1.78-2.69) and gestation
at delivery ≥41 weeks was no longer significant (aOR
0.92, 95% CI 0.62-1.37). Hence, in our multivariable
model of antenatal risk factors for caesarean, prolonged
pregnancy (≥41 weeks) likely acts as a surrogate for
increasing birthweight (Table 2).
Discussion and conclusions
In this cohort of overweight and obese nulliparous
women who laboured at term we have demonstrated,
contrary to our hypothesis, that those requiring first
stage caesarean for failure to progress are not more
likely to have higher serum cholesterol levels at 14–16
weeks’ of gestation compared with overweight and obese
women who deliver vaginally. We have identified clinically
relevant antenatal risk factors among overweight and
obese women for first stage caesarean for failure to
progress at term.
Our findings are novel as the relationship between
maternal serum cholesterol and caesarean for failure to pro-
gress in overweight and obese women has not previously
been described. We have previously demonstrated that
overweight and obesity in nulliparous women confers an
independent risk for caesarean only in the first stage
and not in the second stage of labour [4]. In vitro
studies using term myometrial biopsies from women
undergoing intrapartum caesarean have demonstrated
inhibited contractile amplitude following addition of
cholesterol to the medium, leading to the postulation
that higher serum cholesterol levels may contribute to
sub-optimal myometrial contractility [19]. Oxytocin and
oestrogen receptor function is modulated by the amount
of cholesterol in the uterine myometrial plasma
membranes and extraction of cholesterol from myometrial
plasma membranes in vivo has been demonstrated togreatly enhance spontaneous contractions [20]. Although
we did not find a difference in cholesterol levels in early
pregnancy by mode of delivery, as cholesterol levels
continue to increase with advancing gestation [21], it
is possible that either late pregnancy cholesterol levels
or the magnitude of increase might influence the risk
of caesarean for failure to progress. It was not possible to
explore this relationship in the current study as we did
not collect late pregnancy samples in the SCOPE study
where the focus was early pregnancy risk prediction. We
used non fasting lipids for our study, however lipid
profiles change minimally in response to food intake
[22], and a very large recent study showed that fasting
times showed little association with lipid subclass levels in
a community-based population, suggesting that fasting for
routine lipid levels is largely unnecessary [23]. Non fasting
lipid profiles may be used as standard [24]. Our findings
of several simple antenatal risk factors associated with
caesarean for failure to progress specifically among
overweight and obese nulliparous women are novel and
clinically relevant. Although many studies have identified
risk factors associated with caesarean for failure to
progress in a general obstetric population of mixed BMI
[25], and identified obesity as a risk factor, no studies have
specifically investigated risk factors among overweight and
obese women only. Two studies with populations of
mixed BMI have performed subgroup analyses of obese
women and reported a two to three fold increase in the
rate of caesarean among obese women with short stature
[26,27] but a third study reporting interventions during
labour in relation to height in obese women did not
support this association [28]. An association between
induction of labour and caesarean delivery among
nulliparous women of mixed BMI has previously been
reported [29], particularly for labour arrest [30].
There are some limitations to our study. This study is
a retrospective secondary analysis of prospectively
collected data. We used a definition of regular, painful
uterine contractions with progressive cervical effacement
and dilation and cervical dilatation ≥3 cms for active
labour and this was incorporated into our subsequent
definition of failure to progress in active labour. There are
several published definitions of active labour, however there
is no consistently agreed consensus. Suggested criteria to
diagnose active labour include cervical dilatation
ranging from ≥2 cms [31] to ≥6 cms suggested in a
recent publication [32]. However, this latter definition
of ≥6 cms is applicable only to multiparous women,
as in this study, the average labour curve for nullipar-
ous women did not show a definitive inflection point
at which labour progressed at an accelerated rate [32].
We selected our definition based both on the pre-defined
definition in the SCOPE study protocol which was
consistent with the definitions used in practice at the two
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introduced systematic bias. It is possible our finding
of no effect of early pregnancy cholesterol on the risk
of caesarean for failure to progress in the first stage may be
related to our definition of active labour and subsequent
diagnosis of failure to progress. Further research using an
increased cervical dilatation for definition of active labour
should be considered in future studies.
In summary, we have identified the following antenatal
risk factors for first stage caesarean for failure to
progress among overweight and obese nulliparous
women at term: increasing maternal age, increasing
BMI, reducing height, induction of labour and prolonged
pregnancy. These factors can be incorporated into risk
assessment when planning for delivery in overweight
and obese women. Early pregnancy cholesterol measures
are not useful as part of this risk assessment.
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